Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Prins

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Endocrinology|August 1, 1997
Estrogen and progesterone inhibit vascular smooth muscle proliferationA K Morey, A Pedram, M Razandi, et al.
The Journal of Biological Chemistry|April 22, 1994
Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cellsB A Prins, R M Hu, B Nazario, et al.
Biochemical and Biophysical Research Communications|May 20, 1998
IGF I induction of p53 requires activation of MAP kinase in cardiac muscle cellsP H Wang, G J Schaaf, W H Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1993
Possible novel action of ouabain: allosteric modulation of vascular serotonergic (5-HT2) and angiotensinergic (AT1) receptorsR E Purdy, B A Prins, M A Weber, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Endocrinology|August 1, 1997
Estrogen and progesterone inhibit vascular smooth muscle proliferationA K Morey, A Pedram, M Razandi, et al.
The Journal of Biological Chemistry|April 22, 1994
Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cellsB A Prins, R M Hu, B Nazario, et al.
Biochemical and Biophysical Research Communications|May 20, 1998
IGF I induction of p53 requires activation of MAP kinase in cardiac muscle cellsP H Wang, G J Schaaf, W H Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1993
Possible novel action of ouabain: allosteric modulation of vascular serotonergic (5-HT2) and angiotensinergic (AT1) receptorsR E Purdy, B A Prins, M A Weber, et al.
Pageof 2